Data from a Phase 2b clinical trial showing that  vTv Therapeutics‘s investigational drug, azeliragon, slows cognitive decline in patients with…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
On July 26, a different kind of happening interrupted the usual bustle of activity at this year’s Alzheimer’s Association…
Researchers at the University of Sussex in England have built a protein closely resembling amyloid-β, except for the fact that…
Each year on World Brain Day, July 22 the year, the World Federation of Neurology (WFN) dedicates a brain awareness campaign…
North Carolina-based Muses Labs will show its latest technology and services July 24-28 at the Alzheimer’s Association International Conference…
That running can boost our memory to the same degree or more than brain training is an old observation that still puzzles scientists…
California-based researchers from the Buck Institute for Research on Aging created a method capable of screening substances that might be…
A simple number naming test can identify those with cognitive impairment among elderly individuals, clearly differentiating patients with dementia and…
Amyloid-β plaques accumulating in the brain alone are not enough to cause the dementia that characterizes Alzheimer’s, new research from Johns…
A study at the Indiana University Center for Aging Research, exploring how screening seemingly healthy older people for dementia…